Apimeds Pharmaceuticals US, Inc
APUS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,987 | $8,735 | $250 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,099 | $0 | $0 | $10 |
| Total Curr. Assets | $9,086 | $10,350 | $260 | $13 |
| Property Plant & Equip (Net) | $34 | $13 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $130 | $184 | $0 | $0 |
| Total NC Assets | $164 | $197 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $9,250 | $10,547 | $260 | $13 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $500 | $500 | $624 | $250 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $589 | $183 | $287 | $181 |
| Total Curr. Liab. | $1,089 | $809 | $1,770 | $1,024 |
| LT Debt | $0 | $0 | $250 | $347 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $250 | $347 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,089 | $809 | $2,020 | $1,371 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $126 | $126 | $79 | $79 |
| Retained Earnings | -$9,238 | -$7,457 | -$4,794 | -$4,392 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $17,273 | $0 | $0 | $0 |
| Total Equity | $8,161 | $9,738 | -$1,761 | -$1,358 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $9,250 | $10,547 | $260 | $13 |
| Net Debt | -$6,487 | -$8,235 | $623 | $593 |